Pinto-Prades JL - Search Results

1

Risk attitudes in medical decisions for others: An experimental approach.

Arrieta A, García-Prado A, González P, Pinto-Prades JL. Arrieta A, et al. Health Econ. 2017 Dec;26 Suppl 3:97-113. doi: 10.1002/hec.3628. Health Econ. 2017. PMID: 29285873

2

Health state after treatment: a reason for discrimination?

Abellan-Perpiñan JM, Pinto-Prades JL. Abellan-Perpiñan JM, et al. Health Econ. 1999 Dec;8(8):701-7. doi: 10.1002/(sici)1099-1050(199912)8:8<701::aid-hec473>3.0.co;2-m. Health Econ. 1999. PMID: 10590471

3

Comparing WTP values of different types of QALY gain elicited from the general public.

Pennington M, Baker R, Brouwer W, Mason H, Hansen DG, Robinson A, Donaldson C; EuroVaQ Team. Pennington M, et al. Health Econ. 2015 Mar;24(3):280-93. doi: 10.1002/hec.3018. Epub 2013 Dec 11. Health Econ. 2015. PMID: 25625510

4

Reducing preference reversals: The role of preference imprecision and nontransparent methods.

Pinto-Prades JL, Sánchez-Martínez FI, Abellán-Perpiñán JM, Martínez-Pérez JE. Pinto-Prades JL, et al. Health Econ. 2018 Aug;27(8):1230-1246. doi: 10.1002/hec.3772. Epub 2018 May 16. Health Econ. 2018. PMID: 29770524

5

Sequence effects in time trade-off valuation of hypothetical health states.

Pinto-Prades JL, McHugh N, Donaldson C, Manoukian S. Pinto-Prades JL, et al. Health Econ. 2019 Nov;28(11):1308-1319. doi: 10.1002/hec.3942. Epub 2019 Sep 8. Health Econ. 2019. PMID: 31496009

6

Is the person trade-off a valid method for allocating health care resources?

Pinto Prades JL. Pinto Prades JL. Health Econ. 1997 Jan-Feb;6(1):71-81. doi: 10.1002/(sici)1099-1050(199701)6:1<71::aid-hec239>3.0.co;2-z. Health Econ. 1997. PMID: 9142532

7

Measuring the social importance of concentration or dispersion of individual health benefits.

Rodríguez-Míguez E, Pinto-Prades JL. Rodríguez-Míguez E, et al. Health Econ. 2002 Jan;11(1):43-53. doi: 10.1002/hec.643. Health Econ. 2002. PMID: 11788981

8

Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.

Pinto-Prades JL, Farreras V, de Bobadilla JF. Pinto-Prades JL, et al. Eur J Health Econ. 2008 Feb;9(1):69-78. doi: 10.1007/s10198-007-0041-x. Epub 2007 Apr 20. Eur J Health Econ. 2008. PMID: 17447095

9

Trying to estimate a monetary value for the QALY.

Pinto-Prades JL, Loomes G, Brey R. Pinto-Prades JL, et al. J Health Econ. 2009 May;28(3):553-62. doi: 10.1016/j.jhealeco.2009.02.003. Epub 2009 Mar 3. J Health Econ. 2009. PMID: 19327857

10

The predictive validity of prospect theory versus expected utility in health utility measurement.

Abellan-Perpiñan JM, Bleichrodt H, Pinto-Prades JL. Abellan-Perpiñan JM, et al. J Health Econ. 2009 Dec;28(6):1039-47. doi: 10.1016/j.jhealeco.2009.09.002. Epub 2009 Sep 20. J Health Econ. 2009. PMID: 19833400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page